International Journal of Radiation Oncology*Biology*Physics
Physics contributionBenefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: An analysis of 4DCT datasets
Introduction
In patients presenting with Stage I non–small-cell lung cancer (NSCLC), far higher local control rates have been reported using stereotactic radiotherapy (SRT) (1, 2, 3, 4, 5, 6, 7, 8) than have been reported with conventional fractionated radiotherapy (9). SRT generally combines high-precision irradiation with high fraction doses, and total biologic doses well in excess of 100 Gy. Although the reported clinical toxicity after SRT for lung cancer is low, this may reflect both patient selection (e.g., small peripheral lung cancers) and a relatively short follow-up in most series. The high dose per fraction used can result in toxicity to normal lung tissue and adjacent structures such as the esophagus, spinal cord, and thoracic wall (10); therefore, it is important that treatment portals for SRT should remain as small as possible. Because most SRT approaches use online setup correction protocols, measures to reduce the margins used to account for tumor mobility offer a possible solution for minimizing toxicity.
Recent studies show that individualized, and not standard population-based margins, are necessary for high-precision radiotherapy of Stage I NSCLC (11, 12). Approaches such as breath-hold techniques and respiration-gated radiotherapy have been used to reduce target volumes for lung cancer (13, 14). However, breath-hold techniques are often poorly tolerated by patients with lung cancer (13). Respiratory gating permits a reduction in field sizes, because irradiation can be limited to phases in which the mobile target volume is in a predetermined position. Commercially available gating systems (e.g., the Varian Real-Time Position Management [RPM], Varian Medical Systems, Palo Alto, CA) are already in clinical use (15).
For SRT planning in Stage I NSCLC, use of a single four-dimensional (4D) or respiration-correlated computed tomography (CT) scan was superior to the use of multiple conventional CT scans (16). Because our 4DCT scan technique also uses RPM gating equipment for coregistering respiratory signals, we analyzed 4D scans of 31 patients to establish the benefit with use of respiratory gating in SRT and establish the criteria for identifying patients who could derive significant benefit from this approach.
Section snippets
Methods and materials
A total of 34 tumors in 31 consecutive patients with Stage I NSCLC, who were treated with fractionated SRT using 4DCT scans at the VU Medical Center, Amsterdam were included in this study.
Results
A total of 34 tumors were analyzed. Tumor characteristics are shown in Table 1. There were 24 T1N0 tumors (70.6%) and 10 T2N0 tumors (29.4%). The mean GTVs of T1 and T2 tumors were 4.8 mL and 27.3 mL, respectively. Included were 11 lower lobe tumors, 22 upper lobe tumors, and 1 middle lobe tumor, and 8 tumors were adjacent to the pleura.
Discussion
The reduction of the planning margins required to account for tumor mobility is the subject of active, ongoing research. Most of the patients with Stage I NSCLC who are referred for radiotherapy are ineligible for surgery because of poor pulmonary function (18), which explains an inability to tolerate procedures such as deep-inspiration breath-hold (DIBH) in up to 50% of patients (13). As such, passive respiration-gated radiotherapy would appear to be an ideal approach for reducing the risk of
References (31)
- et al.
Extracranial stereotactic radioablationResults of a phase I study in medically inoperable stage I non-small cell lung cancer
Chest
(2003) - et al.
Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung
Lung Cancer
(2003) - et al.
Stereotactic radiosurgery for lung tumorsPreliminary report of a phase I trial
Ann Thorac Surg
(2003) - et al.
Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancerA 5-year experience
Int J Radiat Oncol Biol Phys
(2001) - et al.
Stereotactic hypofractionated high-dose irradiation for patients with stage I non-small cell lung carcinomaClinical outcomes in 241 cases of a Japanese multi-institutional study [Abstract]
Int J Radiat Oncol Biol Phys
(2003) - et al.
Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC)
Int J Radiat Oncol Biol Phys
(2003) - et al.
The role of radiotherapy in treatment of stage I non-small cell lung cancer
Lung Cancer
(2003) - et al.
Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers
Int J Radiat Oncol Biol Phys
(2003) - et al.
Tumor location cannot predict the mobility of lung tumorsA 3D analysis of data generated from multiple CT scans
Int J Radiat Oncol Biol Phys
(2003) - et al.
Analysis of intrathoracic tumor mobility during whole breathing cycle by dynamic MRI
Int J Radiat Oncol Biol Phys
(2004)
Deep inspiration breath hold and respiratory gating strategies for reducing organ motion in radiation treatment
Semin Radiat Oncol
Respiratory gating for liver tumorsUse in dose escalation
Int J Radiat Oncol Biol Phys
4-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer
Int J Radiat Oncol Biol Phys
Stereotactic single high dose irradiation of lung tumors under respiratory gating
Radiother Oncol
Has 3D conformal radiotherapy improved the local tumor control in stage I non-small cell lung cancer?
Radiother Oncol
Cited by (179)
Practical usefulness of partial-range 4-dimensional computed tomography in the simulation process of lung stereotactic body radiation therapy
2022, Radiation Physics and ChemistryAbsolute dose measurements for lung gated delivery stereotactic body radiation therapy
2021, Radiation Physics and ChemistryFirst clinical evaluation of breathing controlled four-dimensional computed tomography imaging
2021, Physics and Imaging in Radiation Oncology